Recognizes October 13, 2020 as "Metastatic Breast Cancer Awareness Day" in New Jersey.
The recognition of this day serves to not only honor patients and their families affected by metastatic breast cancer but also to galvanize public attention toward the critical need for research that focuses on the metastatic phase of breast cancer. With over 8,260 women in New Jersey alone succumbing to metastatic breast cancer each year, this resolution seeks to underscore the urgency of improving research dedicated to extending patients' lives and enhancing treatment methods.
Assembly Resolution No. 79 recognizes October 13, 2020, as 'Metastatic Breast Cancer Awareness Day' in New Jersey. The legislation aims to raise awareness about metastatic breast cancer, a condition where breast cancer spreads to other parts of the body, which is incurable and significantly impacts patients' life expectancy. This day is marked to remember the significance of ongoing research and highlight the need for further advancements in treatment options for those suffering from this devastating disease.
The passage and recognition of this resolution serve as a symbolic measure to reinforce the importance of state involvement in cancer awareness, particularly concerning metastatic breast cancer, which disproportionately affects various demographic groups. It is an appeal to both the public and state officials to engage in activities and programs that promote better understanding, research, and potentially, improvements to treatment outcomes for patients affected by this illness.
While the resolution is largely supportive and carries the backing of various health and wellness organizations aimed at breast cancer research, points of contention may arise regarding the depth of attention and funding allocated to metastatic breast cancer research compared to other stages of breast cancer. Advocates for increased funding highlight that less than five percent of breast cancer research is currently directed at metastatic cases, despite accounting for 98 percent of breast cancer-related deaths.